Jonas Demant , Stephen Strunge Nilsson , Louise Krohn-Dehli , Anne Øvrehus , Lone Hagens Mygind , Lone W. Madsen , Jacob Søholm , Jeffrey V. Lazarus , Jannet van der Veen , Nina Weis
{"title":"Peer-delivered mail-order self-collection and linkage to treatment for hepatitis C virus infection among users of a harm reduction service in Denmark","authors":"Jonas Demant , Stephen Strunge Nilsson , Louise Krohn-Dehli , Anne Øvrehus , Lone Hagens Mygind , Lone W. Madsen , Jacob Søholm , Jeffrey V. Lazarus , Jannet van der Veen , Nina Weis","doi":"10.1016/j.drugpo.2025.104919","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Hepatitis C virus infection remains a major public health challenge, particularly among people who inject drugs. Despite the availability of highly effective direct-acting antiviral treatment, many remain undiagnosed and untreated. Self-collection for hepatitis C may improve testing uptake in this marginalized population. This study evaluated a peer-assisted, mail-based self-collection model integrated into a harm reduction service in Denmark.</div></div><div><h3>Methods</h3><div>This prospective observational study was conducted from June 2023 to December 2024. Participants were recruited through a peer-led mail-order harm reduction program operated by the non-governmental organization User’s Academy in Copenhagen. Self-collection kits with a dried blood spot finger-prick test were mailed to participants, with peer support provided throughout the care cascade. The primary outcome was the proportion returning the collected sample, and receiving results. Secondary outcomes included assistance with testing, HCV detection, treatment initiation, and cure. Factors associated with test completion were analyzed using adjusted odds ratios.</div></div><div><h3>Results</h3><div>A total of 126 participants were enrolled (median age 44 years; 29 percent women). Forty-four percent completed self-collection and received results; 52 percent of these received assistance. Among completers, 7 percent had detectable hepatitis C virus RNA, and all initiated treatment. Completion was associated with age 40 or older (adjusted odds ratio 3.31, 95 % confidence interval: 1.02 to 11.90) and enrollment in opioid agonist treatment (adjusted odds ratio 3.70, 95 % confidence interval: 0.99 to 15.70). Stimulant use (adjusted odds ratio 0.23, 95 % confidence interval: 0.05 to 0.88) and previous hepatitis C testing (adjusted odds ratio 0.18, 95 % confidence interval: 0.03 to 0.77) were associated with lower completion.</div></div><div><h3>Conclusion</h3><div>A peer-assisted, mail-based hepatitis C self-collection model is feasible and may improve testing and treatment uptake among people who inject drugs.</div></div>","PeriodicalId":48364,"journal":{"name":"International Journal of Drug Policy","volume":"143 ","pages":"Article 104919"},"PeriodicalIF":4.4000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Drug Policy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0955395925002178","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Hepatitis C virus infection remains a major public health challenge, particularly among people who inject drugs. Despite the availability of highly effective direct-acting antiviral treatment, many remain undiagnosed and untreated. Self-collection for hepatitis C may improve testing uptake in this marginalized population. This study evaluated a peer-assisted, mail-based self-collection model integrated into a harm reduction service in Denmark.
Methods
This prospective observational study was conducted from June 2023 to December 2024. Participants were recruited through a peer-led mail-order harm reduction program operated by the non-governmental organization User’s Academy in Copenhagen. Self-collection kits with a dried blood spot finger-prick test were mailed to participants, with peer support provided throughout the care cascade. The primary outcome was the proportion returning the collected sample, and receiving results. Secondary outcomes included assistance with testing, HCV detection, treatment initiation, and cure. Factors associated with test completion were analyzed using adjusted odds ratios.
Results
A total of 126 participants were enrolled (median age 44 years; 29 percent women). Forty-four percent completed self-collection and received results; 52 percent of these received assistance. Among completers, 7 percent had detectable hepatitis C virus RNA, and all initiated treatment. Completion was associated with age 40 or older (adjusted odds ratio 3.31, 95 % confidence interval: 1.02 to 11.90) and enrollment in opioid agonist treatment (adjusted odds ratio 3.70, 95 % confidence interval: 0.99 to 15.70). Stimulant use (adjusted odds ratio 0.23, 95 % confidence interval: 0.05 to 0.88) and previous hepatitis C testing (adjusted odds ratio 0.18, 95 % confidence interval: 0.03 to 0.77) were associated with lower completion.
Conclusion
A peer-assisted, mail-based hepatitis C self-collection model is feasible and may improve testing and treatment uptake among people who inject drugs.
期刊介绍:
The International Journal of Drug Policy provides a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal, and health contexts of psychoactive substance use, both licit and illicit. The journal is particularly concerned to explore the effects of drug policy and practice on drug-using behaviour and its health and social consequences. It is the policy of the journal to represent a wide range of material on drug-related matters from around the world.